Prevention of recurrent stroke in patients with embolic stroke of undetermined source (ESUS) is challenging. The advent of safer anticoagulation in the form of direct oral anticoagulants (DOACs) has prompted e...
Authors:
Klaus K. Witte, Georgios Tsivgoulis, Matthew R. Reynolds, Stelios I. Tsintzos, Simon Eggington, Eleni Ismyrloglou, Julie Lyon, Marianne Huynh, Marta Egea, Bonnie de Brouwer, Paul D. Ziegler, Noreli Franco, Rashmi Joglekar, Sarah C. Rosemas, Shufeng Liu and Vincent Thijs
Citation:
BMC Cardiovascular Disorders
2021
21:160
Content type: Research article
Published on: 31 March 2021